Activation of nitric oxide synthase by β2-adrenoceptors in human umbilical vein endothelium in vitro

British Journal of Pharmacology

Volumn 126, Issue 8, 1999, Pages 1872-1880

  Ferro, Albert ^a   Queen, Lindsay R ^a   Priest, Rachel M ^a   Xu, Biao ^a   Ritter, James M ^a   Poston, Lucilla ^a   Ward, Jeremy P T ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

adrenergic receptors; Human umbilical vein; Nitric oxide; Nitric oxide synthase; Vascular endothelium; Vasodilatation

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 BUTOXY 4 METHOXYBENZYL) 2 IMIDAZOLIDINONE; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ADENYLATE CYCLASE; ARGININE; BETA 2 ADRENERGIC RECEPTOR; BUCLADESINE; CITRULLINE; CYCLIC AMP; FORSKOLIN; ISOPRENALINE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN F2 ALPHA;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; VASODILATATION;

ADENYLATE CYCLASE; ARGININE; CALCIUM; CELLS, CULTURED; CITRULLINE; CYCLIC AMP; CYTOPLASM; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTORS, ADRENERGIC, BETA-2; UMBILICAL VEINS;

EID: 0032960992     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702512     Document Type: Article

References (44)

1. Haydoun, A.R., Emery, P.W., Pearson, J.D. & Mann, G.E. (1990). Substrate-dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells. Biochem. Biophys. Res. Commun., 173, 940-948.
2. Béa. M.-L., Ghaleh, B., Giudicelli, J.-F. & Berdeaux, A. (1994). Lack of importance of NO in β-adrenoceptor-mediated relaxation of large epicardial canine coronary arteries. Br. J. Pharmacol., 111, 981-982.
3. Berkenboom, G., Depierreux, M. & Fontaine, J. (1987). The influence of atherosclerosis on the mechanical responses of human isolated coronary arteries to substance P, isoprenaline and noradrenaline. Br. J. Pharmacol., 92, 113-120.
4. 2-selective adrenoceptor antagonist (ICI 118,551). J. Cardiovasc. Pharmacol., 5, 430-437.
5. G-monomethyl-L-arginine on the β-adrenoceptor-mediated relaxation of rat mesenteric resitance arteries. Life Sci., 52, PL135-PL139.
6. Bogle, R.G., Moncada, S., Pearson, J.D. & Mann, G.E. (1992). Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter. Br. J. Pharmacol., 105, 768-770.
7. Bossaller, C., Habib, G.B., Yamamoto, H., Williams, C., Wells, W. & Henry, P.D. (1987). Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 3′.5′-monophosphate formation in the atherosclerotic human coronary artery and rabbit aorta. J. Clin. Invest., 79, 170-174.
8. 2 purinoceptor-stimulated conversion of arginine to citrulline in bovine endothelial cells is reduced by inhibition of protein kinase C. Biochem. Pharmacol., 52, 1849-1854.
9. Buxton, B.F., Jones, C.R., Molenaar, P. & Summers, R.J. (1987). Characterization and autoradiographic localization of β-adrenoceptor subtypes in human cardiac tissues. Br. J. Pharmacol., 92, 299-310.
10. Corson, MA., James, N.L., Latta, S.E., Nerem, R.M., Berk, B.C. & Harrison, D.G. ( 1996). Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ. Res., 79, 984-991.
11. Dawes, M., Chowienczyk, P.J. & Ritter, J.M. (1997). Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by β-adrenergic agonists in human forearm. Circulation, 95, 2293-2297.
12. Drexler, H., Hayoz, D., Munzel, T., Hornig, B., Just, H., Brunner, H.R. & Zelis, R. (1992). Endothelial function in chronic congestive heart failure. Am. J. Cardiol., 69, 1596-1601.
13. G-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5′-N-ethylcarboxamidoadenosine or salbutamol in conscious rats. Br. J. Pharmacol., 103, 1725-1732.
14. Gold, M.E., Bush, P.A. & Ignarro, L.J. (1989). Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. Biochem. Biophys. Res. Commun., 164, 714-721.
15. Graier, W.F., Groschner, K., Schmidt, K. & Kukovetz, W.R. (1992). Increases in endothelial cyclic AMP levels amplify agonist-induced formation of endothelium-derived relaxing factor (EDRF). Biochem. J., 288, 345-349.
16. 2+ concentrations and cGMP levels in endothelial cells. Cell. Signalling. 2, 369-375.
17. Graves, J. & Poston, L. (1993). β-Adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: A role for the endothelium and nitric oxide. Br. J. Pharmacol., 108, 631-637.
18. Gray, D.W. & Marshall, I. (1992). Novel signal transduction pathway mediating endothelium-dependent β-adrenoceptor vasorelaxation in rat thoracic aorta. Br. J. Pharmacol., 107, 684-690.
19. Howell, R.E., Albeda, S.M., Daise, M.L. & Levine, E.M. (1988). Characterization of β-adrenergic receptors in cultured human and bovine endothelial cells. J. Appl. Physiol., 65, 1251-1257.
20. Kamata, K., Miyata, N. & Kasuya, Y. (1989). Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats. J. Pharmacol. Exp. Therap., 249, 890-894.
21. 2-adrenoceptors activated by (-) adrenaline in the rat sino-atrial node. Naunyn Schmiedeberg's Arch. Pharmacol., 333, 73-76.
22. Kuriyama, H., Ito, Y., Suzuki, H., Kitamura, K. & Itoh, T. (1982). Factors modifying contraction-relaxation cycle in vascular smooth muscles. Am. J. Physiol., 243, H641-H662.
23. Larosa, G. & Forster, C. (1996). Coronary β-adrenoceptor function is modified by the endothelium in heart failure. J. Vasc. Res., 33, 62-70.
24. Lefroy, D.C., Donnelly, L.E., McEwan, J.R. & Macdermot, J. (1993). Phorbol ester enhances activation of adenylate cyclase in bovine aortic endothelial cells. Life Sci., 54, 87-94.
25. 3H-ICI 118,551 and blocking potency of ICI 118,551. Naunyn Schmiedeberg's Arch. Pharmacol., 331, 40-51.
26. Macallister, R.J., Fickling, S.A., Whitley, G.S. & Vallance, P. (1994). Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. Br. J. Pharmacol., 112, 43-48.
27. Macdonald, P.S., Dubbin, P.M. & Dusting, G.J. (1987). β-Adrenoceptors on endothelial cells do not influence release of relaxing factor in dog coronary artries. Clin. Exp. Pharmacol. Physiol., 14, 525-534.
28. 2--dependently converts L-arginine into an activator of soluble guanylyl cyclase. Biochem. Biophys. Res. Commun., 164, 678-685.
29. Mcdonald, K.K., Zharikov, S., Block, E.R. & Kilberg, M.S. (1997). A caveolar complex between the cationic amino acid transporter I and endothelial nitric-oxide synthase may explain the 'arginine paradox'. J. Biol. Chem., 272, 31213-31216.
30. Mitchell, J.A., Hecker, M., Änggärd, E.E. & Vane, J. R. (1990). Cultured endothelial cells maintain their L-arginine level despite the continuous release of EDRF. Eur. J. Pharmacol., 182, 573-576.
31. Molenaar, P., Malta, E., Jones, C.R., Buxton, B.F. & Summers, R.J. (1988). Autoradiographic localization and function of β-adrenoceptors on the human internal mammary artery and saphenous vein. Br. J. Pharmacol., 95, 225-233.
32. Moncada, S., Rees, D.D., Schulz, R. & Palmer, R.M.J. (1991). Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc. Natl. Acad. Sci. USA, 88, 2166-2170.
33. Mulsch, A., Bassenge, E. & Busse, R. (1989). nitric oxide synthesis in endothelial cytosol: Evidence for a calcium-dependent and a calcium-independent mechanism. Naunyn Schmiedeberg's Arch. Pharmacol., 340, 767-770.
34. Palmer, R.M.J. & Moncada, S. (1989). A novel citrulline forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem. Biophys. Res. Commun., 158, 348-352.
35. Parent, R., Al-Obaidi, M. & Lavallée, M. (1993). Nitric oxide formation contributes to β-adrenergic dilation of resistance coronary vessels in conscious dogs. Circ. Res., 73, 241-251.
36. Priest, R.M., Hucks, D. & Ward, J.P.T. (1997). Noradrenaline, β-adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the rat. Br. J. Pharmacol., 122, 1375-1384.
37. Rebich, S., Devine, J.O. & Armstead, W.M. (1995). Role of nitric oxide and cAMP in β-adrenoceptor-induced pial artery vasodilation. Am. J. Physiol., 268, H1071-H1076.
38. Rosenkranz-Weiss, P., Sessa, W.C., Milstien, S., Kaufman, S., Watson, C.A. & Pober, J.S. (1994). Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells: Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J. Clin. Invest., 93, 2236-2243.
39. Rubanyi, G. & Vanhoutte, P.M. (1995). Endothelium-removal decreases relaxations of canine coronary arteries caused by β-adrenergic agonists and adenosine. J. Cardiovasc. Pharmacol., 7, 139-144.
40. Salomon, Y., Londos, C. & Rodbell, M. (1974). A highly sensitive adenylate cyclase assay. Anal. Biochem., 58, 541-548.
41. - and nitric oxide synthase in human endothelial cells: Association with membrane hyperpolarization. J. Physiol., 489, 183-192.
42. +) and nitric oxide synthesis in human fetal endothelial cells. J. Physiol., 499, 135-140.
43. Steinberg, S.F., Jaffe, E.A. & Bilezikian, J.P. (1984). Endothelial cells contain beta adrenoceptors. Naunyn Schmiedeberg's Arch. Pharmacol., 325, 310-313.
44. Summers, R.J., Molenaar, P., Stephenson, J.A. & Jones, C.R. (1987). Autoradiographic localization of receptors in the mammalian cardiovascular system. Clin. Exp. Pharmacol. Physiol., 14, 437-447.